Follow
Iratxe Macias Garcia
Iratxe Macias Garcia
PhD
Verified email at osakidetza.eus
Title
Cited by
Cited by
Year
Osteoporosis and the potential of cell-based therapeutic strategies
I Macías, N Alcorta-Sevillano, CI Rodríguez, A Infante
International journal of molecular sciences 21 (5), 1653, 2020
732020
Stratification and therapeutic potential of PML in metastatic breast cancer
N Martín-Martín, M Piva, J Urosevic, P Aldaz, JD Sutherland, ...
Nature communications 7 (1), 12595, 2016
592016
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria
P Urquiza, A Laín, A Sanz-Parra, J Moreno, G Bernardo-Seisdedos, ...
Science translational medicine 10 (459), eaat7467, 2018
532018
Deciphering the relevance of bone ECM signaling
N Alcorta-Sevillano, I Macías, A Infante, CI Rodríguez
Cells 9 (12), 2630, 2020
452020
Crucial role of Lamin A/C in the migration and differentiation of MSCs in bone
N Alcorta-Sevillano, I Macías, CI Rodríguez, A Infante
Cells 9 (6), 1330, 2020
372020
Cutting edge endogenous promoting and exogenous driven strategies for bone regeneration
I Macías, N Alcorta-Sevillano, A Infante, CI Rodríguez
International journal of molecular sciences 22 (14), 7724, 2021
172021
Hereditary tyrosinemia type I–associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate
I Macias, A Laín, G Bernardo-Seisdedos, D Gil, E Gonzalez, ...
Journal of Biological Chemistry 294 (35), 13051-13060, 2019
162019
Murine femur micro-computed tomography and biomechanical datasets for an ovariectomy-induced osteoporosis model
M Stephens, K López-Linares, J Aldazabal, I Macias, N Ortuzar, ...
Scientific Data 8 (1), 240, 2021
82021
Therapeutic targeting of fumaryl acetoacetate hydrolase in hereditary tyrosinemia type I
J Gil-Martínez, I Macias, L Unione, G Bernardo-Seisdedos, F Lopitz-Otsoa, ...
International journal of molecular sciences 22 (4), 1789, 2021
82021
Educating EVs to improve bone regeneration: getting closer to the clinic
A Infante, N Alcorta-Sevillano, I Macías, CI Rodríguez
International Journal of Molecular Sciences 23 (3), 1865, 2022
52022
Murine animal models in osteogenesis imperfecta: The quest for improving the quality of life
N Alcorta-Sevillano, A Infante, I Macías, CI Rodríguez
International Journal of Molecular Sciences 24 (1), 184, 2022
42022
PHARMACOLOGICAL CHAPERONES AS A NOVEL THERAPY AGAINST TYROSINEMIA TYPE I
J Gil-Martinez, I Macias, L Unione, G Bernardo-Seisdedos, ...
HEPATOLOGY 74, 731A-732A, 2021
2021
Molecular basis of tyrosinemia and identification of possible pharmacological chaperones targets
I Macias, A Sanz, A Lain, O Millet
PROTEIN SCIENCE 24, 87-87, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–13